EXAS.Exact Sciences CORP

Form 4: Exact Sciences GC Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report

📋All filings for Exact Sciences CORP
🔒Login to Follow

Exact Sciences' SVP, General Counsel & Secretary, James Herriott, sold 1,500 shares of common stock for $60 per share under a pre-arranged trading plan.

Summary

  • James Herriott, SVP, General Counsel & Secretary of Exact Sciences Corp (EXAS), reported a transaction involving company common stock.
  • On October 9, 2025, Mr. Herriott disposed of 1,500 shares of Common Stock.
  • The shares were sold at a price of $60 per share.
  • This transaction was executed pursuant to a Rule 10b5-1 trading plan, which was established on March 3, 2025.
  • Following the sale, Mr. Herriott directly holds 14,085 shares of Common Stock.
  • An additional 1,556 shares are held indirectly in a 401(k) Plan, bringing the total beneficially owned shares to 15,641.
  • Mr. Herriott also holds 37,434 vested and unvested options to purchase shares of Common Stock and restricted stock units.

Sentiment

Score: 5

Explanation: The transaction is a pre-planned insider sale under a Rule 10b5-1 plan, which typically indicates a routine liquidity event rather than a change in management's outlook on the company's prospects. Therefore, the sentiment is neutral.

Future Outlook

No forward-looking statements or guidance are provided in this insider transaction report.

Industry Context

This filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitor analysis.

Stakeholder Impact

  • Shareholders: The sale represents a minor, pre-planned disposition of shares by a senior executive, which is unlikely to have a significant impact on shareholder sentiment or company valuation.

Key Dates

DateDescription
March 3, 2025Date Rule 10b5-1 trading plan was entered into.
October 9, 2025Date of the reported transaction (sale of common stock).
October 10, 2025Date the Form 4 was signed by attorney-in-fact.

Recommendation

hold

The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan. This type of transaction is generally not indicative of a change in company fundamentals or management's long-term outlook, and therefore does not warrant a change in investment recommendation based solely on this filing.

Keywords

EXAS, Exact Sciences, insider trading, Form 4, stock sale, James Herriott, 10b5-1 plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.